← Leaderboards
Salim S Virani
Michael E Debakey Va Medical Center
$61,295
Attributed
$122,589
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $122.6K · FY2019–25$200K$150K$100K$50K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$122,589 · 1
VA$0 · 2
By mechanism
G11$122,589 · 1
I01$0 · 2
Top collaborators
- Sankar Dass Navaneethan5 shared
- Ali H Mokdad1 shared
Most similar at Michael E Debakey Va Medical Center
Same institution · by research overlap
- Sankar Dass Navaneethan$3,448,418
Others in their field
Other Emerging Leaders on “Manuals”
- Leonard Freedman · Leidos Biomedical Research, Inc.$31,000,000
- Patricia Shifflett · Westat, Inc.$16,650,520
- Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr$16,509,191
- Bradley G Hammill · Duke University$15,773,864
- Brian Custer · Vitalant$10,344,162
- Leonard Freedmand · Leidos Biomedical Research, Inc.$10,000,000
Research focus
ManualsTrainingCommunitiesMedical CenterReportingEventLifeMortalityPilot TrialPharmaceutical PreparationsCessation Of LifeInterviewNatural Language ProcessingPilot ProjectsCardiovascular DiseasesCommunication AidData SetDoseAmbulatory Care FacilitiesGuidelinesCardiovascular SystemHigh RiskCaringInformatics
Grant awards (11)
Optimizing Renin Angiotensin System Blocker Use among Veterans with Kidney Disease$0
I01 · FY2025 · VA
Developing a Supportive Research Administration Ecosystem$122,589
G11 · FY2024 · AI · contact PI
Optimizing Renin Angiotensin System Blocker Use among Veterans with Kidney Disease$0
I01 · FY2024 · VA
Optimizing Renin Angiotensin System Blocker Use among Veterans with Kidney Disease$0
I01 · FY2023 · VA
Determining and targeting reasons for low statin use to improve guideline-concordant statin therapy in high-risk patients$0
I01 · FY2023 · VA · contact PI
Optimizing Renin Angiotensin System Blocker Use among Veterans with Kidney Disease$0
I01 · FY2022 · VA · contact PI
Determining and targeting reasons for low statin use to improve guideline-concordant statin therapy in high-risk patients$0
I01 · FY2021 · VA · contact PI
Determining and targeting reasons for low statin use to improve guideline-concordant statin therapy in high-risk patients$0
I01 · FY2020 · VA · contact PI
Optimizing Renin Angiotensin System Blocker Use among Veterans with Kidney Disease$0
I01 · FY2020 · VA · contact PI
Determining and targeting reasons for low statin use to improve guideline-concordant statin therapy in high-risk patients$0
I01 · FY2019 · VA · contact PI
Determining and targeting reasons for low statin use to improve guideline-concordant statin therapy in high-risk patients$0
I01 · FY2019 · VA · contact PI